Chip for interventional imaging enters market

Article

Other headlinesiCAD hosts webinars on prostate cancer

Chip for interventional imaging enters market
Chip technology that promises to extend the product lifecycle, while reducing the size and energy consumption of interventional radiology equipment is now on the market. The chip, a field-programmable gate array (FPGA), incorporates ContextVision’s GOPView iRVPlus. This software is designed specifically to process fluoroscopy images, such as those accompanying angioplasty or stent replacement, during which real-time images are used to guide catheters. It was unveiled at RSNA 2008.

iCAD hosts webinars on prostate cancer
Computer-aided detection specialist iCAD is reaching out to a broad array of specialists involved in the diagnosis and treatment of prostate cancer, in an effort to highlight advanced image analysis and workflow solutions developed by the company. Two webinars, entitled “Prostate MRI – A Paradigm Shift in Prostate Cancer Diagnosis and Management” and scheduled for Oct. 15 and Nov. 10, will focus on how MR combines with iCAD’s quantitative image analysis software VividLook to support improved prostate cancer management. The company hopes to interest radiologists, urologists, oncologists, radiation oncologists, surgeons, technologists and other referring physicians in the course, which will include clinical case reviews. These reviews will demonstrate prostate cancer detection in patients with previously negative prostate biopsy and rising PSA values, as well as the use of dynamic contrast enhanced MR and CAD to monitor prostate cancer response to radiation therapy.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.